Pharmaceutical News and Articles

Sapience Therapeutics Receives FDA Orphan Drug Designation for ST316, a First-in-Class β-catenin Antagonist, for the Treatment of Familial Adenomatous Polyposis (FAP)

TARRYTOWN, N.Y., December 19, 2024 Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide thera

Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia

Nurix Therapeutics, Inc. (Nasdaq NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with

FDA Approves Ensacove (ensartinib) for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

FDA Approves Ryoncil (remestemcel-L-rknd) Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft Versus Host Disease

U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome

FDA Updates Meaning of 'Healthy' on Food Labels

would be considered healthy, as would other nutrient-rich foods like whole grains, dairy, eggs, beans, lentils, seafood, lean meat, nuts and seeds. It s critica

FDA Expands Approval of Vtama to Include Atopic Dermatitis

the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 years and older.The cream, an aryl hydrocarbon receptor agonist, was previousl

Dual-Biomarker Algorithm Can Inform Osteoarthritis Diagnosis

A new diagnostic test using a dual-biomarker algorithm can inform osteoarthritis diagnosis with high accuracy, according to a study published online Dec. 18 in

Cold Weather Deaths Keep Rising for Americans

It s a perhaps unexpected consequence of climate change that periods of deep cold now occur more frequently during American winters, despite an overall trend to

Team Sports, but Not Overall Physical Activity, in Young Childhood Linked to Later Executive Function

Moderate-to-vigorous physical activity (MVPA) in young childhood is not associated with executive function in middle childhood, but participation in team sports